Last reviewed · How we verify
Treatment of type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes
Approved treatments
- Ertugliflozin 15 mg · Pfizer
- Ertugliflozin 5 mg · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Treatment of type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes patent landscape — cliff calendar, originator estates, attackable patents
- Treatment of type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes treatment landscape brief
- Treatment of type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes treatment updates RSS
Frequently asked questions about Treatment of type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes
What drugs treat Treatment of type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes?
Tracked treatments include Ertugliflozin 15 mg, Ertugliflozin 5 mg.
What is the treatment for Treatment of type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes?
Standard treatment for Treatment of type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes includes Ertugliflozin 15 mg, Ertugliflozin 5 mg. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Treatment of type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes patent cliff · Treatment of type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes CI report
- Treatment: Ertugliflozin 15 mg · Pfizer
- Treatment: Ertugliflozin 5 mg · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing